These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10617232)

  • 1. Long-term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation.
    Rayes N; Seehofer D; Bechstein WO; Müller AR; Berg T; Neuhaus R; Neuhaus P
    Clin Transplant; 1999 Dec; 13(6):447-52. PubMed ID: 10617232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-centre study.
    Manns MP; Neuhaus P; Atkinson GF; Griffin KE; Barnass S; Vollmar J; Yeang Y; Young CL;
    Transpl Infect Dis; 2001 Mar; 3(1):16-23. PubMed ID: 11429035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Famciclovir treatment in transplant recipients with HBV-related liver disease: disappointing results.
    Berenguer M; Prieto M; Rayón M; Bustamante M; Carrasco D; Moya A; Pastor MA; Gobernado M; Mir J; Berenguer J
    Am J Gastroenterol; 2001 Feb; 96(2):526-33. PubMed ID: 11232701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
    Rayes N; Seehofer D; Hopf U; Neuhaus R; Naumann U; Bechstein WO; Neuhaus P
    Transplantation; 2001 Jan; 71(1):96-101. PubMed ID: 11211203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation.
    Seehofer D; Rayes N; Berg T; Neuhaus R; Müller AR; Hopf U; Bechstein WO; Neuhaus P
    Transpl Int; 2000; 13(4):290-6. PubMed ID: 10959482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study.
    Krüger M; Tillmann HL; Trautwein C; Bode U; Oldhafer K; Maschek H; Böker KH; Broelsch CE; Pichlmayr R; Manns MP
    Liver Transpl Surg; 1996 Jul; 2(4):253-62. PubMed ID: 9346658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
    de Man RA; Bartholomeusz AI; Niesters HG; Zondervan PE; Locarnini SA
    J Hepatol; 1998 Oct; 29(4):669-75. PubMed ID: 9824278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation.
    Seehofer D; Rayes N; Naumann U; Neuhaus R; Müller AR; Tullius SG; Berg T; Steinmüller T; Bechstein WO; Neuhaus P
    Transplantation; 2001 Oct; 72(8):1381-5. PubMed ID: 11685107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatitis B-reinfection or de novo-infection after liver transplantation with famciclovir--how effective is it?
    Rayes N; Neuhaus R; Naumann U; Hopf U; Haller GW; Bechstein WO; Neuhaus P
    Transplant Proc; 1999; 31(1-2):481-2. PubMed ID: 10083200
    [No Abstract]   [Full Text] [Related]  

  • 10. Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation.
    Singh N; Gayowski T; Wannstedt CF; Wagener MM; Marino IR
    Transplantation; 1997 May; 63(10):1415-9. PubMed ID: 9175803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation.
    Haller GW; Bechstein WO; Neuhaus R; Raakow R; Berg T; Hopf U; Neuhaus P
    Transpl Int; 1996; 9 Suppl 1():S210-2. PubMed ID: 8959829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
    Seehofer D; Rayes N; Bechstein WO; Naumann U; Neuhaus R; Berg T; Hopf U; Langrehr JM; Steinmüller T; Platz KP; Müller AR; Neuhaus P
    Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trial.
    Wedemeyer H; Böker KH; Pethig K; Petzold DR; Flemming P; Tillmann HL; Vollmar J; Bastürk M; Goldmann E; Griffin KE; Haverich A; Manns MP
    Transplantation; 1999 Nov; 68(10):1503-11. PubMed ID: 10589947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up.
    Yoshida EM; Ma MM; Davis JE; Fischer KP; Kneteman NM; Erb SR; Tyrrell DL; Bain VG
    Can J Gastroenterol; 1998 Mar; 12(2):125-9. PubMed ID: 9559207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
    Shapira R; Daudi N; Klein A; Shouval D; Mor E; Tur-Kaspa R; Dinari G; Ben-Ari Z
    Transplantation; 2002 Mar; 73(5):820-2. PubMed ID: 11907436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of recurrent delta-positive hepatitis B infection to seronegativity with famciclovir after liver transplantation.
    Klein M; Geoghegan J; Schmidt K; Böckler D; Korn K; Wittekind C; Scheele J
    Transplantation; 1997 Jul; 64(1):162-3. PubMed ID: 9233718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of recurrent hepatitis B in two liver transplant recipients treated with famciclovir.
    Han SH; Kinkhabwala M; Martin P; Holt C; Murray N; Seu P; Rudich S; Hiserodt D; Imagawa D; Busuttil RW
    Am J Gastroenterol; 1998 Nov; 93(11):2245-7. PubMed ID: 9820407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
    Tillmann HL; Trautwein C; Bock T; Böker KH; Jäckel E; Glowienka M; Oldhafer K; Bruns I; Gauthier J; Condreay LD; Raab HR; Manns MP
    Hepatology; 1999 Jul; 30(1):244-56. PubMed ID: 10385663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.
    Seehofer D; Rayes N; Neuhaus R; Berg T; Müller AR; Bechstein WO; Neuhaus P
    Transpl Int; 2000; 13 Suppl 1():S359-62. PubMed ID: 11112032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B: progress in the last 15 years.
    Villamil FG
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S59-66. PubMed ID: 12362301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.